Long-term effects of discontinuing renin-angiotensin system inhibitors in COVID-19

Respirology. 2022 Sep;27(9):788-790. doi: 10.1111/resp.14306. Epub 2022 Jun 7.
No abstract available

Keywords: COVID-19; SARS-CoV-2; antihypertensive drugs; hypertension; renin-angiotensin-system inhibitors (RASi).

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin Receptor Antagonists / pharmacology
  • Angiotensin Receptor Antagonists / therapeutic use
  • Antihypertensive Agents / pharmacology
  • Antihypertensive Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Humans
  • Hypertension* / drug therapy
  • Renin-Angiotensin System
  • SARS-CoV-2

Substances

  • Angiotensin Receptor Antagonists
  • Antihypertensive Agents